Matisse Capital
- SEC CIK
- 0001668256
- Latest filing
- Aug 12, 2026
SPRY holding history
ARS Pharmaceuticals, Inc. in every 13F filed by Matisse Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SPRY overviewAll 13F holders of SPRYFull Q2 2026 holdings
- Shares (Q2 2026)
- 65,701
- Value
- $526.3K
- % of portfolio
- 0.2%
- Quarters held
- 6
- Since Q1 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 65,701 | $526.3K | 0.2% | −1,528−2.3% | Reduced | Holders |
| Q1 2026 | 67,229 | $539.8K | 0.2% | +11,668+21.0% | Added | Holders |
| Q4 2025 | 55,561 | $647.3K | 0.3% | −2,230−3.9% | Reduced | Holders |
| Q3 2025 | 57,791 | $580.8K | 0.3% | +1,077+1.9% | Added | Holders |
| Q2 2025 | 56,714 | $989.7K | 0.5% | +1,000+1.8% | Added | Holders |
| Q1 2025 | 55,714 | $700.9K | 0.4% | +55,714 | New | Holders |